Arkolith/Insider Trading/AQST/Form 4

Korczynski Sherry

Chief Commercial OfficerAquestive Therapeutics, Inc. (AQST) · full profile →Form 4 · filed Mar 11, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$66K
Net Open-Market Flow
-$66K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 10, 2026Sell(S)16K$4.17$66K241K
Mar 9, 2026Grant(A)75K—$0257K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 9, 2026Grant(A)43K$4.29$182K43K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001214659-26-003142) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML